Bilateral synchronous low-grade adenosquamous carcinoma of the breast: A Case report with review of the current literature  by Senger, J.L. et al.
CASE  REPORT  –  OPEN  ACCESS
International Journal of Surgery Case Reports 14 (2015) 53–57
Contents lists available at ScienceDirect
International  Journal  of  Surgery  Case  Reports
journa l h omepage: www.caserepor ts .com
Bilateral  synchronous  low-grade  adenosquamous  carcinoma  of  the
breast:  A  Case  report  with  review  of  the  current  literature
J.L.  Sengera,  P.  Meiersb, R.  Kanthanc,∗
a Department of Plastic Surgery, University of Alberta, Canada
b Department of Surgery, University of Saskatchewan, Canada
c Department of Pathology & Laboratory Medicine, University of Saskatchewan, Canada
a  r  t  i  c  l  e  i  n  f  o
Article history:
Received 27 May  2015
Accepted 26 June 2015
Available online 13 July 2015
Key words:
Low-grade adenosquamous carcinoma
Metaplastic breast cancer
Syringomatous adenoma of the nipple
Sclerosing lesions of the breast
a  b  s  t  r  a  c  t
INTRODUCTION:  Low-grade  adenosquamous  carcinoma  (LGASC)  is a rare,  unique  variant  of  meta-
plastic  breast  carcinoma,  characterized  by clinical  indolence  and low-grade  cytomorphology.  Being
clinically  asymptomatic  with  indeﬁnite  imaging  characteristics,  diagnosis  is  solely  dependent  on
histopathology.
PRESENTATION  OF  CASE:  A  68-year-old  woman  presented  to the  Breast  Health  Center  with  mammogram-
detected  left-sided  retroareolar  calciﬁcations.  She  had  a three-year  history  of  non-progressive  bilateral
nipple inversion,  and  was otherwise  asymptomatic.  Left  breast  biopsy  revealed  atypical  metaplastic  squa-
mous epithelial  cells.  Subsequently  a wire-guided  lumpectomy  diagnosed  a  syringomatous  adenoma  of
the  nipple.  A  surveillance  MRI  identiﬁed  a contralateral  breast  lesion,  which  on  core  biopsy  showed  an
atypical  adenosquamous  lesion.  Bilateral  central  mastectomies  with  bilateral  sentinel  node  biopsies  were
undertaken.
Histopathological  review  of both  breast  specimens  conﬁrmed  the  unique  features  of adenosquamous
carcinoma  identiﬁed  by  an  inﬁltrative  pattern  of small  rounded  compressed  angulated  glands  with  squa-
mous  differentiation  and  low-grade  cytomorphology.  The  tumors  were  triple  negative  [ER,  PR,  HER2].
The  sentinel  lymph  nodes  were  negative.
CONCLUSION:  Bilateral  synchronous  LGASC  of  the  breasts  is  exceedingly  uncommon  and  remains  a
diagnostic  and  therapeutic  challenge.  Despite  being  triple  negative,  due  to its  indolent  behavior,  recog-
nition  of  this  unusual  primary  breast  malignancy  is  important  as  it has  a more  favorable  prognosis.  Yet,
due to its rarity,  there  are no  guidelines  for best  practice  management  regarding  the  role  of  adjuvant
therapy.
© 2015  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Low-grade adenosquamous carcinoma (LGASC) of the breast is
exceedingly uncommon, belonging to the family of ‘metaplastic
breast cancers’ which represent <1% of all breast carcinomas [1]. In
contrast to the highly aggressive, triple-negative, chemo-resistant
features of most metaplastic breast cancers, LGASC portends an
indolent course, with a low metastatic potential and thus an
improved prognosis [2,3]. Reports of LGASC in the published litera-
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ture are limited. We  herein describe a case of bilateral synchronous
LGASC, an extremely rare occurrence.
2. Case report
A 68-year-old female was referred with suspicious clusters of
2.5 × 5.5 cm calciﬁcations in the retroareolar left breast on mam-
mogram (Fig. 1) and an unremarkable ultrasound. On risk factor
stratiﬁcation, menses began at age 10, and at age 45 she underwent
a hysterectomy and unilateral oophorectomy for benign disease
that required hormone replacement therapy for three years. She
was nulliparous with no signiﬁcant family history of breast/ovarian
cancer. Physical exam was  non-contributory, with no evidence of
nipple discharge, skin changes, or palpable breast masses or axillary
lymphadenopathy. Breasts were symmetrical with a long-standing
history of bilateral nipple inversion.
http://dx.doi.org/10.1016/j.ijscr.2015.06.040
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Mammogram of the left breast shows irregular spiculated calciﬁcations in a retroareolar distribution on both compressed views.
Fig. 2. Excision biopsy of left breast lesion. Photomicrograph of haematoxylin and eosin stained slide at low (A), medium (B) and high (C) magniﬁcations show a focal nodular
lesion (A) with compressed duct-like structures (*) surrounded by ﬁbrotic stromal cells (#) (B) admixed with proliferating atypical squamous metaplastic cells (→) and
lymphocytic inﬁltration ()ˆ (C).
Stereotactic biopsy of the left breast identiﬁed irregular groups
of metaplastic atypical squamous epithelial cells with granulo-
matous inﬂammation and calciﬁcations raising the suspicion of
microinvasive carcinoma. With the possibility of cancer, the patient
elected to undergo a wire-guided lumpectomy. Histopathology
identiﬁed mildly proliferative ﬁbrocystic changes with duct hyper-
plasia, sclerosing adenosis, apocrine metaplasia, ﬁbroadenomatoid
nodules and multiple intraductal papillomas with a focal nodu-
lar lesion composed of proliferating squamous metaplastic cells
with compressed duct-like structures surrounded by ﬁbrotic stro-
mal  cells [Fig. 2A–C], diagnosed as syringomatous adenoma of the
nipple with no evidence of invasive/in-situ carcinoma.
Due to the discordant biopsy and lumpectomy pathology, and
in keeping with patient preference, wide excision of the left
breast was planned, which was temporarily postponed due to
comorbid pulmonary disease. A follow-up MRI  nine months post-
operatively discovered an incidental spiculated nodule in the
retroareolar right breast. An ultrasound-guided right breast core
biopsy identiﬁed an atypical adenosquamous lesion suspicious for
low-grade carcinoma. She was  medically optimized and under-
went bilateral central mastectomies with sentinel lymph node
biopsies.
Histopathology conﬁrmed low-grade adenosquamous carci-
noma of the right breast with atypical inﬁltrating metaplastic
squamous cells surrounded by stromal lamellar ﬁbrosis and lym-
phocytic aggregates in the background of a complex sclerosing
lesion (Figure 3A–C). The residual left breast tissue showed simi-
lar features supporting the presence of bilateral LGASC (Fig. 4A–C).
Tumour cells were negative for ER, PR, and Her2, and the lymph
nodes were negative for metastatic disease.
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Fig. 3. Right breast central mastectomy. Photomicrograph of haematoxylin and eosin stained slide at low (A), medium (B) and high (C) magniﬁcations show a complex
sclerosing lesion (A) with inﬁltrating duct-like structures (*) (B) and single inﬁltrating atypical squamous cells with metaplastic squamous cells lining the ducts (→) (C).
Fig. 4. Left breast central mastectomy. Photomicrograph of haematoxylin and eosin stained slide at low (A), medium (B) and high (C) magniﬁcations show similar features
of  inﬁltrating atypical squamous cells in the background of dense stromal lamellar ﬁbrosis and lymphocytic aggregates.
Postoperatively, radiation and medical oncologists decided
there were no evidence-based guidelines for adjuvant chemora-
diation and she is well at 4 years follow-up.
3. Literature review
A review of the published literature using PubMed and Med-
line identiﬁed all reports of LGASC of the breast. Case reports and
series were analyzed for the following data: patient age, lateral-
ity of lesion, clinical presentation, diagnostic imaging techniques,
histopathology, treatment and outcomes. Case reports/series that
describe sporadic cases of LGASC without providing clinical data
were excluded.
A  total of 18 manuscripts (1987 to present) describing 109
cases of LGASC are summarized in Table 1 [1–18]. Patients’ ages
range from 19 to 88, with two cases of bilateral LGASC being
reported. Majority of patients (89%) presented with a palpable
breast mass (97/109). Almost all patients underwent mammo-
gram and ultrasound as their initial radiologic work-up, with
calciﬁcations and/or a hypoechoic mass being most commonly
described. Patients underwent surgical excision (78/109) or a mas-
tectomy (31/109). Though early studies by Rosen(36%) and Van
Hoeven(20%) reported relatively frequent rates of recurrence (4/11
and 5/25), most patients reported in the recent literature had no
subsequent disease progression.
4. Discussion
LGASC of the breast was described by Rosen and Ernsberger in
1987 [18] and has since been reported sporadically in the literature.
Currently the WHO  classiﬁes LGASC under “metaplastic carci-
noma”, a group of tumours deﬁned by neoplastic epithelium that
differentiates into squamous cells and/or mesenchymal-appearing
elements. Clinically, LGASC occur in patients of any age (19-88)
and commonly present as a palpable mass rather than an inciden-
tal ﬁnding on mammography [12,17,19]. Though LGASC is locally
invasive, and despite a ‘triple-negative’ proﬁle, metastases are rare
and patients have an overall good prognosis, different from other
metaplastic carcinomas of the breast [1,3,6,7,17,18].
LGASC is nonspeciﬁc on mammographic and sonographic imag-
ing, mimicking both benign and malignant neoplasms. Commonly
a spiculated lesion on mammogram and an irregular hypoechoic
mass on ultrasonography are identiﬁed. LGASC radiology is limited
to case-reports and case-series with no pathognomonic ﬁndings;
features include a nodular or stellate appearance on mammogram
and a solid irregular hypoechoic mass with poorly-deﬁned borders
on ultrasound [7].
Accurate diagnosis of LGASC preoperatively is often impossi-
ble at ﬁne-needle aspiration cytology (FNAC) due to a paucity of
classical cytological features of malignancy [5,11,14–16]. At core
biopsy the overall architecture is not appreciable, and intraoper-
ative frozen section is limited due to sampling [13,19]; therefore,
preoperative conﬁrmation is rare, as seen in the biopsy from the
left breast in our case. Nuclear uniformity/enlargement, monomor-
phism, keratin debris, and the presence of metaplastic squamous
cells may  reduce false negative rates on FNAC [5,13]. Immuno-
markers such as p63 may  aid in recognizing the squamous elements
that facilitate exact tumor typing; however, this requires a high
preoperative index of suspicion [12].
Due to the risk of local recurrence, aggressive treatment with
wide breast excision or mastectomy is recommended as micro-
scopic peripheral extensions of this tumor within the normal
parenchyma affects the evaluation of the post-resection margins
[19]. Other authors argue that due to the indolent natural history
of these tumors with low metastatic potential, local excision with
margins of 1 cm is sufﬁcient, provided lymph nodes are clinically
unremarkable [3].
It is not uncommon for LGASC of the breast to coexist with
additional breast pathologies. Several authors report associa-
tions with sclerosing lesions [3,12], ﬁbroadenoma (FA), phyllodes
tumors, carcinoma in-situ, ﬁbroepithelial lesions [3], and adeno-
myoepithelioma [20]. LGASC commonly occurs in the background
of radial scars (RSL)/complex sclerosing lesions(CSL), as seen in
our case. Among 20 RSLs reported by Wilsher, 60% contained
adenosquamous proliferation/papilloma, indistinguishable from
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Table 1
Literature review “low-grade adenosquamous carcinoma of the breast”—PubMed & Medline 1987 to present. Exclusion criteria—refer to manuscript.
Reference #cases Age (y) Later-
ality
Presentation Imaging Biopsy ﬁndings Treatment Coexisting lesions Node
biopsy
Outcome
Tan [3] 8 29–49 NS Palpable mass (8) MG (5)
U/S (8)
CBx (7): Phyllodes (3),
LGASC (3), ﬁbrocystic
changes
EXBx: IDC + ACC + LGAC
SgEX (4)
Mx  (4)
FA, ACC,
IDC, RSL, CSL,
phyllodes
SLNB (5) NS
Cha  [4] 1 69 Rt Palpable mass MG –
microcalciﬁcations
CBx—‘ﬁbroadenoma with
squamous metaplasia’
Mammotome
excision
None NS NS
Bataillon [5] 3 54 Lt Palpable mass MG FNA—malignancy
Frozen section—FEL
SgEX SLNB 3 years post-op ILC
BRCA-2
56  Lt MG  detected MG,  U/S-guided
FNA
FNA—tubular carcinoma
CNBx—FC
Lumpectomy ILC (contralateral) SLNB 6 years disease-free
81  Rt Palpable mass MG  FNA—AC with squamous
metaplasia
Lumpectomy
Chemo
IDC, +ve nodes
(contralateral)
ALND 6 years disease-free survival
Wilsher  [6] 1 45 B/L Palpable mass (Rt) U/S, MG FNA: FA
CBx—CSL
Nipple-sparing Mx  CSL, FA SLNB Incidental ﬁnding LGASC left
breast in six radial scars
Scali  [7] 10 30–81 NS Palpable mass (5)
MG ﬁnding (3)
Nipple changes (2)
MG  (10)
U/S (10)
Scattered glandular and
squamous components
Mx  (3), BCT (7),
Radiation (7),
Chemo
NS NS Follow-up 2–11.5 years
No metastases
1 local recurrence
Alipour  [8] 1 33 Lt Inﬂammation &
abscess
MG,  U/S, CT chest,
abdo, pelvis
Abscess wall —IDC BCT, chemo,
radiation
Abscess ALND 4 years no recurrence
Chuthapisith [9] 1 55 Lt Palpable mass MG:  calciﬁed mass
U/S
EBx—LGASC with
osseous metaplasia
SgEX Sclerosing FA NS Repeated recurrences: 4
years, 1 year, 4 months
Kawaguchi [10] 30 20–85 Rt (15)
Lt (15)
Palpable mass (29) NS CBx (14)
EXBx (12)
EXBx (29)
Mx
DCIS, SL (6),
Papilloma
SLNB (2) NS
Bigotti  [2] 1 65 Rt Palpable mass U/S, MG FNAC
CBx—IDC
Chemo
Mx
None ALND Disease-free at 17 months
post-op
Sironi  [11] 1 74 Lt MG  spiculated
nodule
U/S-guided FNAC FNA—malignant
epithelial cells
SgEX None NS NS
Agrawal [12] 1 19 Lt Palpable mass U/S: hypoechoic
mass
CBx atypical
adenosquamous
EBx—adenosquamous
lesion
Mx  RSL None No disease recurrence
Noel  [1] 1 62 Rt U/S hypoechoic
mass
U/S
MRI—5 mm  nodule
CBx: LGASC SgEX None NS BRCA-1 +ve
Ho  [13] 4 51–62 Lt (3)
Rt
MG  detected (2)
Palpable mass (2)
U/S-guided FNAC
U/S (2)
MG (2)
FNAC—atypical cells
CBx (2)—DCIS, atypical SL
Frozen section
SgEX, Mx (2), EXBx,
Chemo
IDC
DCIS
CSL
ALND (3) No disease recurrence
Ferrara  [14] 1 57 Lt Painless mass NS FNAC—malignancy
Frozen section—cancer
BCT
Radiotherapy
Spindled stellate
cells
ALND Disease-free 3y postop
Shizawa [15] 1 47 Lt Palpable mass MG  & U/S—no
cancer
FNAC—atypical
squamous cells
EXBx
Mx  None ALND Well 16 months
Krigman  (1996) [16] 1 57 Rt Palpable mass MG:  nodular mass FNA—rare atypical cells EXBx Papillomatosis
SA
NS NS
Van  Hoeven [17] 32 33–88 Rt (17)
Lt (14)
B/L (1)
Palpable mass (32) NS NS EXBx (19)
Mx  (13)
FC, Papilloma (12),
AME (3), CS (3)
ALND (12) 12–124 months follow-up
5/25 recurrences
Rosen  (1987) [18] 11 42-76 Rt (6)
Lt (3)
Palpable mass (11) NS EXBx (7) Mx  (4)
EXBx (7)
Osteocartilagin-ous
metaplasia
ALND (4) 4 recurrences (1–3.5 years)
ACC: adenoid cystic carcinoma; ALND: axillary lymph node dissection; AME: adenomyoepithelioma; BCT: breast conserving therapy; CBx: core biopsy; CS: collagenous spherulosis; EXBx: excisional biopsy; FC: Fibrocystic change;
FEL:  ﬁbroepithelial lesion; FNAC: ﬁne needle aspiration cytology; Lt: left; MG: mammogram; Mx:  mastectomy; NS: not speciﬁed; Rt: right; SA: sclerosing adenosis; SgEX: surgical excision; SLNB: sentinel lymph node biopsy;
U/S:  ultrasound
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LGASC, suggesting adenosquamous proliferation of RSL may  be a
benign precursor to LGASC [21].
On gross examination, LGASCs have irregular borders, ﬁrm
consistency, and a white/yellow cut surface [19]. On histology,
LGASC shows glandular and squamous differentiation in a stel-
late/inﬁltrating conﬁguration. Small tubular glands in collagenized
stroma with low-grade cytologic atypia and rare mitoses/necrosis
may  be seen; however, precise identiﬁcation is challenging [7].
Thus, accurate recognition of LGASC from ‘mimickers’ is difﬁ-
cult; such lesions include benign ﬁbrosclerosing lesions (sclerosing
adenosis, radial scar), tubular carcinoma, and syringomatous
adenoma of the nipple (SAN). Differentiation of LGASC from
ﬁbrosclerosing lesions is supported by the absence of lobular con-
ﬁguration in LGASC. Histologically, LGASC differs from tubular
carcinoma by the presence of squamous differentiation [19].
Traditionally, LGASC and SAN have been regarded as separate
entities; accurate distinction remains a considerable challenge as
seen in the primary excision sample of the left breast in our case.
Reports in the literature have mislabeled these lesions [5,19], with
some authors currently using the terms ‘LGASC’ and ‘inﬁltrat-
ing syringomatous adenoma’ synonymously [1,13,14]. Both lesions
are locally aggressive with a propensity for local recurrence. An
emerging school of thought proposes that LGASC and SAN are
the same lesion of putative metaplastic origin, though arising
in different anatomical locations. SAN is proposed to arise from
the pluripotent adnexal epidermal keratinocytes with dual fol-
licular and sweat gland differentiation, while LGASC is from the
myoepithelium [14,22]. Thus, while LGASC is located within the
breast parenchyma, SAN is limited to the epidermal layer of the
skin/nipple. On microscopy, LGASC and SAN are deemed “essen-
tially identical” [19]; both are composed of well-differentiated
inﬁltrative glands with an angulated/polliwog appearance. Differ-
entiation between LGASC and SAN may  therefore be impossible,
particularly if the former involves the nipple areolar complex as
seen in our case (Figs. 2 & 4). Both LGASC and SAN are positive
for CK5/6 and p63 [10], and negative for ER, PR, and HER2 [5,21].
Boecker et al. showed LGASC and SAN contain p63+/K5/K14+ tumor
cells, K10+ squamous, and K8/18+ glandular cells. They concluded
that these two lesions are identical with p63+/K5/14+ cells playing
a role in neoplastic transformation of both entities [22].
This index case is the third bilateral LGASC reported. Van Hoeven
described LGASC of the left breast with subsequent development
1 year later in the right breast [17]. Additional clinical details are
unavailable. Wilsher and Snook described a right-sided LGASC with
a second focus of LGASC within six radial scars in the left breast 1
month later [6]. Such bilateral cases raise the possibility of LGASC
being a complex multicentric disease and therefore perhaps mas-
tectomy should be recommended as the standard practice of care
rather than wide local excision that can cause increased recurrences
as seen in the case-series of Rosen (36%) [18] and Van Hoeven (20%)
[17].
5. Conclusions
Given the rarity of LGASC of the breast, a large number of
‘unknowns’ that continue to pose clinical challenges include: the
precise etiology/histopathogenesis and the lack of pathognomonic
diagnostic radiological and cyto-histo-pathological features. The
precise relationship between LGASC and SAN remains disputed
with speculation of whether they represent a continuing spec-
trum or are two independent progressive proliferative breast
lesions. Increased clinical recognition of this unusual primary
triple-negative breast cancer is imperative due to its clinical indo-
lence and slow evolution with excellent survival.
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